Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostate in paediatric von Willebrand disease
2009-017753-34Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of factor viii + von Willebrand factor in von Willebrand disease (VWD), sponsored by CSL Limited. Primary endpoints: Haemostatic efficacy in non-surgical bleeding, surgery, or prophylaxis and Pharmacokinetic profile of Biostate. Started Jan 2010; status: completed.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2009-017753-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017753-34.